SCHEMBL15768648

SCHEMBL15768648

C=Cc1ccc(C(=O)C=Cc2ccc(N(CC)CC)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.75
MAPK1 P28482 2/20 0.75
TLR9 Q9NR96 2/20 0.75
KMT2A Q03164 2/20 0.75
ALDH1A1 P00352 2/20 0.75
MEN1 O00255 1/20 0.75
USP2 O75604 1/20 0.75
POLB P06746 1/20 0.75
RECQL P46063 1/20 0.75
TDP1 Q9NUW8 1/20 0.75
L3MBTL1 Q9Y468 1/20 0.75
NPSR1 Q6W5P4 1/20 0.61
CRHBP P24387 1/20 0.54
CRHR2 Q13324 1/20 0.54
MAOB P27338 4/20 0.53
NPC1 O15118 1/20 0.51
CASP3 P42574 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CYP1B1 Q16678 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15768647 1.00 MAPT (0.75) MAPTMAPK1TLR9KMT2AALDH1A1
SCHEMBL12963867 1.00 MAPT (0.75) MAPTMAPK1TLR9KMT2AALDH1A1
SCHEMBL2909651 0.93 MAPT (0.86) MAPTMAPK1TLR9KMT2AALDH1A1
SCHEMBL2909650 0.93 MAPT (0.86) MAPTMAPK1TLR9KMT2AALDH1A1
SCHEMBL25218075 0.87 MAPT (0.77) MAPTMAPK1TLR9KMT2AALDH1A1
SCHEMBL4542805 0.87 MAPT (0.77) MAPTMAPK1TLR9KMT2AALDH1A1
SCHEMBL25221826 0.87 MAPT (0.77) MAPTMAPK1TLR9KMT2AALDH1A1
SCHEMBL5950679 0.87 MAPT (0.77) MAPTMAPK1TLR9KMT2AALDH1A1
SCHEMBL5950678 0.87 MAPT (0.77) MAPTMAPK1TLR9KMT2AALDH1A1
SCHEMBL25194301 0.87 MAPT (0.77) MAPTMAPK1TLR9KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140163037-A1 SCREENING METHODS FOR IDENTIFYING SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS TRANA DISCOVERY, INC. (US) 2014-06-12 US claimed
US-10316371-B2 Screening methods for identifying specific Staphylococcus aureus inhibitors TRANA DISCOVERY, INC. (US) 2019-06-11 US disclosed
US-20140163037-A1 SCREENING METHODS FOR IDENTIFYING SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS TRANA DISCOVERY, INC. (US) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163037-A1 SCREENING METHODS FOR IDENTIFYING SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS NSUN3, RNGTT, TRMT1 MAPT 2009/4885MAPK1 1908/4885TLR9 3899/4885
US-10316371-B2 Screening methods for identifying specific Staphylococcus aureus inhibitors NSUN3, RNGTT, TRMT1 MAPT 2009/4885MAPK1 1908/4885TLR9 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.